Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$17.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Healthylife®Do not use Baclofen 10mg x 4 tablets if you are taking or using a monoamine oxidase inhibitor (MAOI) within the last six months. This is a medicine that isoxidely metabolised by the liver, and does not affect the metabolism of other medicines. Baclofen 10mg x 8 tablets may harm an already has an infection.
Healthylife provides each product information found in this page with a full list of recalls and supplements containing products or materials we review. Healthylife provides a summary of all recalls and Supplements we have reviewed, including those we have not reviewed. If you have specific questions about our products or materials, please read our (e.g. Disclaimer)
Healthylife delivers all orders to: Aarhus, Denmark
Healthylife offers returns within 14 working days for all products leftin its original packagingor if larger units have not been returned
Healthylife ships all orders to: Aarhus, Denmark
Healthylife£17.95£15.95
/€17.Store in cool, dry place. Do not refrigerate. Keep out of reach of children. Do not use on pets. Do not give to pets. Do not store in the bathroom. Keep container tightly closed. Store at room temperature. Do not store above 25°C.
Each film coated tablet contains:
Adults and children 14 years of age and older:
Take 1 g of BACLOFEN at least 2 hours before and at least 4 hours after diazepam for up to 8 hours. Do not take more than 4 g in 24 hours.
Adults and children 25 years and over:
Do not take more than 1 g of BACLOFEN in 24 hours.
Do not use:
In children under 14 years:
In children under 25 years:
In children under 24 years:
If symptoms persist for more than 4 hours, stop use and seek medical help.
Do not use if:
•you are allergic to any of the ingredients of this product or any of the ingredients listed at the end of this leaflet
•you have had liver problems after taking diazepam or have had an abnormal or abnormal liver function
•you have had or are about to have a seizure or have a stomach ulcer or bleeding problem
•you have had or are planning to have surgery.
The content on this page has been supplied to bigmountaindrugs.com by an independent third party contracted to provide information for this work.
Health care professional cannot, but without consulting a doctor. Please consult with your doctor or another healthcare professional if you have any concerns or questions about using this product. Unless a doctor or another healthcare professional provides a alternative, your product should not be used. This product is not intended to be used for cure or prevent, prevention of seizures or for the treatment of alcohol addiction.
Product contents for baclofen overdose:
The content on this page is provided solely for informational purposes and should not be construed to contain any legal or health advice. Please seek medical advice before taking any medication and for specific diagnosis or treatment.
This product is not intended to be used for treating addiction. Do not use in any way that suggests that you are not a candidate for medical treatment or you should not be prescribed any medication. If you have diabetes or other medical problems, or are taking other medications, you should not use baclofen.
Q: What is baclofen used for?
A: Baclofen is used to treat muscle spasms and pain caused by multiple sclerosis, spinal cord injury, or certain types of stroke.
Q: How long does baclofen take to work?
A: Baclofen works for up to 4 hours after ingestion.
Q: What are the side effects of baclofen?
A: Some people may experience side effects such as drowsiness, dizziness, or headache, which can be relieved by discontinuing use or increasing the dosage over a period of time.
Background:Baclofen is a muscle relaxant with some potential anticholinergic properties. It is a non-selective gamma-aminobutyric acid (GABA)-B receptor agonist which has been demonstrated in the rat brain and other animal models of neurological disorders.
Methods:A double-blind placebo-controlled, single-dose study was conducted to determine the effect of oral baclofen (80 mg/kg/day) in a group of healthy volunteers. Two weeks after baclofen treatment, the results of two randomized studies were compared with the results of two placebo-controlled studies.
Results:The results of the two studies were significant in a dose-dependent manner (p <0.01). In the baclofen group, the average plasma concentrations of baclofen were significantly lower than those in the placebo group at both doses. In addition, in the baclofen group, the average plasma concentration of baclofen was significantly lower than that in the placebo group at all doses. No significant difference in the mean plasma concentration of baclofen between the two groups was observed, and the effect was similar in the two groups at doses of 40 mg/kg/day and 80 mg/kg/day.
Conclusions:Baclofen is a relatively safe and well-tolerated drug in a wide range of patients with cerebral edema.
Baclofen (a non-selective gamma-aminobutyric acid (GABA)-B receptor agonist) is a derivative of GABA-B receptor agonist baclofen. In vitro studies have shown that baclofen has a similar affinity for the GABA-B receptor in the brain and spinal cord. In clinical studies, baclofen is administered in the dose range of 10-80 mg/kg/day. In these studies, the effects of baclofen on cerebral functions were assessed in a variety of animals.Baclofen (citalopram) is a prescription drug which is used to treat depression and anxiety disorders. It is available in a generic form and is available in a variety of dosages. In the United States, baclofen is a prescription drug used to treat patients who have been diagnosed with major depressive disorder. The Food and Drug Administration (FDA) has approved baclofen as a controlled substance for use in the United States.
Baclofen (citalopram) is a non-selective gamma-aminobutyric acid (GABA)-B receptor agonist. The chemical name for the drug is baclofen. The most common side effect of baclofen is muscle spasm, with the most common side effect occurring in about 6% to 8% of patients. The most common side effect of baclofen is muscle rigidity, with the most common side effect occurring in about 6% to 7% of patients. The most common side effect of baclofen is muscle pain. Baclofen (citalopram) is available in a generic form. The side effects are mostly muscle spasm and rigidity, with the most common side effect occurring in about 6% to 8% of patients. In a study of patients who received baclofen (citalopram) for depression and anxiety, the most common side effect occurring in about 6% to 8% of patients was muscle rigidity, with the most common side effect occurring in about 6% to 7% of patients. In patients who received baclofen (citalopram), the most common side effect occurring in about 6% to 7% of patients was muscle rigidity, with the most common side effect occurring in about 6% to 7% of patients.Conflict of interest:Baclofen has been granted patent on its ability to activate the GABA-B receptor. No other patent has been granted regarding the ability of baclofen to activate the GABA-B receptor in vivo. However, a search for patents regarding the ability of baclofen to activate the GABA-B receptor has been performed.
In a recent study published inThe Journal of Neurosurgery, the authors found that in children with spastic cerebral palsy, baclofen may be more effective than other non-steroidal anti-inflammatory drugs (NSAIDs) at controlling the spasticity resulting from neuro-musculoskeletal disorders. Furthermore, baclofen may improve cerebral function and may alleviate symptoms of spasticity resulting from neuro-musculoskeletal conditions such as cerebral palsy and post-traumatic cerebral palsy.
This study was funded by a grant from Pfizer (USA).
A total of 39 children with cerebral palsy, spastic cerebral palsy, and other neurological disorders, were included. The children were randomly divided into two groups of children: one group received placebo and the other group received baclofen (20 mg/kg, orally). The two groups were matched for age, gender, and weight.
The children in the baclofen group received the lowest dose of baclofen (20 mg/kg, orally) for a total of 12 weeks and then were randomly assigned into two groups: the first group received placebo and the second group received baclofen (20 mg/kg, orally). The baclofen group also received a placebo (control) while the baclofen group received a placebo (control). The baclofen group received baclofen at the same dose as the placebo group.
The baclofen group received a total of 40 mg baclofen (100 mg) per day for 12 weeks. At the end of the 12-week baclofen group (Group A), a total of 30 healthy children (age of 3.7 years, weight of 12 kg, and gender of male and female) were recruited from the pediatric hospital for the baclofen group. In the baclofen group, the children in the placebo group received the lowest dose of baclofen (20 mg/kg, orally) and the baclofen group received the lowest dose of baclofen (20 mg/kg, orally) for 12 weeks.
The children in the baclofen group received a total of 40 mg baclofen (100 mg) per day for 12 weeks. In Group B, the children in the placebo group received a total of 40 mg baclofen (100 mg) per day for 12 weeks. At the end of the 12-week baclofen group (Group B), a total of 30 healthy children (age of 3.5 years, weight of 12 kg, and gender of female) were recruited from the pediatric hospital for the baclofen group.
This study was a randomized, double-blind, crossover, open-label, dose-response study. The study protocol was approved by the Ethics Committee of the Sichuan University of Medicine (No.: E-12-05).
The study population consisted of 3,921 children who received baclofen at a dose of 20 mg/kg of baclofen. The baclofen group included 30 children who were not eligible for inclusion in the study because they had a normal movement disorder (DSM-IV-R). The baclofen group also included 60 children who received a placebo (control) while the baclofen group received a placebo (control).
At the end of the 12-week baclofen group (Group B), a total of 90 healthy children were recruited from the pediatric hospital for the baclofen group.
After the enrollment of the children, their parents, caregivers, and healthcare professionals were instructed to visit the child every 2 or 4 weeks. The baclofen group was randomly divided into two groups (Group A and B).
In the first group, the children in the baclofen group received a total of 40 mg baclofen (100 mg) per day for 12 weeks.
Baclofen (Diazepam) Tablets are used to treat certain muscle spasms and stiffness and in the treatment of epilepsy.
Baclofen is a muscle relaxant that is used to treat spasms caused by Parkinson's disease, epilepsy, and multiple sclerosis. It works by slowing down the movement of certain muscles, which reduces the stiffness and spasms.
Baclofen is available in various forms, including tablets, oral suspension, injection, and topical cream. Each tablet contains diazepam, which is an active ingredient used to help relieve muscle spasms and stiffness. Tablets and oral suspensions provide effective and convenient solutions to treat spasms and stiffness caused by Parkinson's disease, epilepsy, and multiple sclerosis.
Baclofen is an anti-spastic agent. The medication reduces the concentration of a neurotransmitter called gamma-aminobutyric acid (GABA), which is involved in the alleviation of spasms and stiffness caused by Parkinson's disease and epilepsy.
Stade de France Pharmacy